Passed in 1994, the Dietary Supplement Health & Education Act (DSHEA) established a strong, comprehensive regulatory framework for dietary supplements where none existed before. Nearly 30 years later, DSHEA should protect the 21st century consumer who has access to an ever-expanding dietary supplement marketplace. A modernized regulatory structure will protect public health and reinforce the credibility of the dietary supplement category, allowing it to play a more influential role in the healthcare system.
As consumers take control of their healthcare routines, more people are turning to dietary supplements to provide a boost to their wellbeing. Modernized regulations are needed to meet growing consumer demand, strengthen confidence in dietary supplements, and keep pace with the growth of the industry.
It’s a common misconception that the dietary supplements category is not regulated, when in fact it is regulated by multiple government agencies, with manufacturers and retailers also managing responsibility throughout the process.
Pursuant to 16 C.F.R. § 1.31, through this petition, Petitioners respectfully request that FTC withdraw the notice of penalty offenses that were sent to nearly 700 companies.
If you are in the consumer healthcare industry, you probably know about GMPs, or Good Manufacturing Practices. But what do they specifically mean when it comes to dietary supplements, and how do VMS companies prepare for an FDA inspection?
Don't miss CHPA President & CEO, Scott Melville's insights on the consumer healthcare industry for the year ahead. Check out this article from Chain Drug Review.
Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville released a statement today in response to a recent report published in the Journal of the American Medical Association (JAMA).
CHPA President and CEO Scott Melville released a statement in response to Senator Durbin’s and Senator Braun’s Introduction of the Dietary Supplement Listing Act of 2022.
The Consumer Healthcare Products Association issued a statement from President and CEO Scott Melville regarding the Food and Drug Administration’s (FDA) fiscal year 2023 budget request.
From the wild west to mainstream products, listen to how the dietary supplements industry continues to mature from the perspective of Duffy MacKay, CHPA's Senior Vice President of Dietary Supplements.
